Effects of Tranexamic Acid Irrigation on Impacted Third Molar Surgery
Investigation of the Effects of Tranexamic Acid Solution Irrigation on Bleeding, Surgical Field Visibility, and Postoperative Edema in the Extraction of Horizontally Impacted Third Molars
1 other identifier
observational
20
1 country
1
Brief Summary
Tranexamic acid (TXA) is an effective hemostatic agent used to reduce blood loss and the need for transfusion. It is a relatively safe drug with minimal significant side effects. The most commonly reported complications include nausea, diarrhea, and occasional orthostatic reactions. The increased risk of thromboembolic events associated with the drug is the most serious complication; however, this has not been reported in most clinical studies and remains uncertain. Based on experience from other types of surgeries, tranexamic acid appears to be safe for use without an increased risk of venous thrombosis. To mitigate systemic absorption and minimize undesirable side effects, TXA can be applied topically rather than intravenously, reducing the risk of venous thromboembolism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 27, 2025
CompletedFirst Posted
Study publicly available on registry
February 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2026
CompletedJune 24, 2025
June 1, 2025
1.2 years
January 27, 2025
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative edema
Anatomical landmarks, including gonion (Go), ala nasi (AN), tragus (Tr), and lateral canthus (Ka), will be marked with methylene blue for measurement purposes. The distances between lateral canthus and gonion, tragus and commissure, and gonion and ala nasi will be measured preoperatively (just before the procedure begins) and on postoperative day 3, when maximum edema is expected, and the values will be recorded.
3 days
Secondary Outcomes (2)
intraoperative bleeding
during the surgery time
intraoperative vision scale
during the surgery
Study Arms (2)
saline irrigation group
In the double-blind, controlled, randomized study, only saline will be used as the irrigation solution in the control group patients.
tranexamic acid Irrigation group
In the double-blind, controlled, randomized study, saline with tranexamic acid solution will be used as the irrigation solution in the study group patients.
Interventions
in the study group, a combination of two ampules of Tranexamic acid solution mixed with saline will be used. Intraoperative bleeding, surgical field visibility, and postoperative edema will be monitored.
In control group, saline will be used for irrigation.Intraoperative bleeding, surgical field visibility, and postoperative edema will be monitored.
Eligibility Criteria
community sample
You may qualify if:
- Indicated for the Extraction of Bilaterally Impacted Third Molars with Bone Retention.
- Systemically healthy patients aged 14-40 years with no bleeding disorders.
You may not qualify if:
- Patients with systemic diseases affecting general health.
- Patients diagnosed with any bleeding disorder.
- Patients with advanced infection or cysts associated with the impacted tooth.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bezmialem Vakıf Universty
Istanbul, Fatih, 34093, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2025
First Posted
February 4, 2025
Study Start
January 1, 2025
Primary Completion
March 1, 2026
Study Completion
March 10, 2026
Last Updated
June 24, 2025
Record last verified: 2025-06